Sinopep-Allsino Bio Pharmaceutical Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sinopep-Allsino Bio Pharmaceutical Co., Ltd.

Why is Sinopep-Allsino Bio Pharmaceutical Co., Ltd. ?

Negative results in Sep 25

DEBT-EQUITY RATIO (HY) Highest at 60.35 %
INTEREST COVERAGE RATIO(Q) Lowest at 879.16
RAW MATERIAL COST(Y) Grown by 6.78% (YoY)

Underperformed the market in the last 1 year

Even though the market (China Shanghai Composite) has generated returns of 22.49% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -16.38% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sinopep-Allsino Bio Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Sinopep-Allsino Bio Pharmaceutical Co., Ltd.

-33.79%

-0.91

49.65%

China Shanghai Composite

16.67%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

49.05%

EBIT Growth (5y)

174.39%

EBIT to Interest (avg)

12.15

Debt to EBITDA (avg)

0.69

Net Debt to Equity (avg)

0.45

Sales to Capital Employed (avg)

0.36

Tax Ratio

9.76%

Dividend Payout Ratio

34.19%

Pledged Shares

Institutional Holding

ROCE (avg)

8.26%

ROE (avg)

9.49%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.40

EV to EBIT

26.96

EV to EBITDA

18.15

EV to Capital Employed

3.23

EV to Sales

7.97

PEG Ratio

Dividend Yield

ROCE (Latest)

11.98%

ROE (Latest)

15.91%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 518.56 MM

NET SALES(9M)

At CNY 1,524.1 MM has Grown at 21.71%

NET PROFIT(9M)

Higher at CNY 445.54 MM

-19What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 60.35 %

INTEREST COVERAGE RATIO(Q)

Lowest at 879.16

RAW MATERIAL COST(Y)

Grown by 6.78% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.99 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 3 times

INTEREST(Q)

Highest at CNY 18.31 MM

Here's what is working for Sinopep-Allsino Bio Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 518.56 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

At CNY 1,524.1 MM has Grown at 21.71%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Profit

Higher at CNY 445.54 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Here's what is not working for Sinopep-Allsino Bio Pharmaceutical Co., Ltd.

Interest

At CNY 18.31 MM has Grown at 30.41%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 879.16

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at 60.35 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at CNY 18.31 MM

in the last five periods and Increased by 30.41% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 0.99 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 3 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 6.78% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales